Crane Co
NYSE:CR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Crane Co
NYSE:CR
|
US |
|
Cytek Biosciences Inc
NASDAQ:CTKB
|
US |
|
E
|
Enbridge Inc
LSE:0KTI
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CR's stock price target?
Price Target
245.82
USD
According to Wall Street analysts, the average 1-year price target for CR is 245.82 USD with a low forecast of 191.09 USD and a high forecast of 265.65 USD.
What is the Revenue forecast for Crane Co?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 5 years is 10%.
What is the Gross Profit forecast for Crane Co?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 5 years is 10%.
What is the Operating Income forecast for Crane Co?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 5 years is 15%.
What is the Pre-Tax Income forecast for Crane Co?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 17%.
What is the Net Income forecast for Crane Co?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 5 years is 12%.